Bio-Rad Laboratories (BIO) Finished Goods (2009 - 2022)

Bio-Rad Laboratories (BIO) has 14 years of Finished Goods data on file, last reported at $309.9 million in Q2 2022.

• On a quarterly basis, Finished Goods fell 6.18% year-over-year to $309.9 million in Q2 2022; TTM through Jun 2022 was $309.9 million, a 6.18% decrease from a year earlier, with the FY2021 full-year figure at $312.6 million, down 8.97% from the prior year.
• Finished Goods for Q2 2022 stood at $309.9 million, up from $306.0 million in the prior quarter.
• Over the last five years, Finished Goods for BIO reached as high as $354.1 million in Q1 2018 and fell as low as $298.3 million in Q4 2019.
• Historically, Finished Goods has averaged $327.5 million across 5 years, with a median of $331.6 million in 2018.
• Across the five-year window, Finished Goods slipped 9.81% in 2019 and grew 15.12% in 2020, its largest moves.
• Year by year, Finished Goods stood at $330.8 million in 2018, then retreated by 9.81% to $298.3 million in 2019, then grew by 15.12% to $343.4 million in 2020, then retreated by 8.97% to $312.6 million in 2021, then slipped by 0.88% to $309.9 million in 2022.
• Per Business Quant data, the three most recent Finished Goods figures were $309.9 million in Q2 2022, $306.0 million in Q1 2022, and $312.6 million in Q4 2021.